ACC 2013.

The most relevant articles and presentations, daily report from the ACC 2013 congress, held in San Francisco, 9 – 11 march

Como cada año se realizó la Convocation Ceremony en la que tuvo lugar el recambio de autoridades del American College of Cardiology. El presidente saliente Dr. William Zoghbi, dio lugar a la asunción del nuevo presidente, Dr. John Gordon Harold, quien ofreció su mensaje de bienvenida. Participaron autoridades de las sociedades de cardiología de todo el mundo y en representación de SOLACI nuestro presidente el Dr. Oscar Mendiz. También se tomó juramento a nuevos Fellows del ACC entre los cuales se encontraban destacados miembros de SOLACI.

If you cannot view the articles, click here

More articles by this author

EuroPCR 2024

Here are the most important scientific articles of the EuroPCR 2024 Scientific Sessions. If you cannot view the articles, click here

ACC 2024

Here are the most important scientific articles of the ACC 2024 Scientific Sessions. If you cannot view the articles, click here

AHA 2023

Here are the most important scientific articles of the AHA 2023 Congress. If you cannot view the articles, click here

TCT 2023

Here are the most important scientific articles of the TCT 2023 Congress. If you cannot view the articles, click here

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...